Tapinarof and the future of topical treatments in plaque psoriasis
- PMID: 33508393
- DOI: 10.1016/j.jaad.2021.01.056
Tapinarof and the future of topical treatments in plaque psoriasis
Conflict of interest statement
Conflicts of interest None disclosed.
Comment in
-
Reply to: Tapinarof cream 1% once daily and benvitimod 1% twice daily are two distinct topical medications.J Am Acad Dermatol. 2021 Sep;85(3):e203. doi: 10.1016/j.jaad.2021.05.027. Epub 2021 May 26. J Am Acad Dermatol. 2021. PMID: 34048851 No abstract available.
-
Tapinarof cream 1% once daily and benvitimod 1% twice daily are 2 distinct topical medications.J Am Acad Dermatol. 2021 Sep;85(3):e201-e202. doi: 10.1016/j.jaad.2021.04.103. Epub 2021 Jun 7. J Am Acad Dermatol. 2021. PMID: 34111499 No abstract available.
-
A novel topical treatment for plaque psoriasis: Benvitimod/tapinarof.J Am Acad Dermatol. 2022 Mar;86(3):e137-e138. doi: 10.1016/j.jaad.2021.10.053. Epub 2021 Nov 3. J Am Acad Dermatol. 2022. PMID: 34742862 No abstract available.
Comment on
-
Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor-modulating agent.J Am Acad Dermatol. 2021 Apr;84(4):1059-1067. doi: 10.1016/j.jaad.2020.10.085. Epub 2020 Nov 3. J Am Acad Dermatol. 2021. PMID: 33157177 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
